CAM
DRNA
Cormorant Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-3,481,471
| Closed | -$37.2M | – | 73 |
|
|
2018
Q4 | $37.2M | Sell |
3,481,471
-75,198
| -2% | -$804K | 3.02% | 9 |
|
|
2018
Q3 | $54.3M | Sell |
3,556,669
-44,285
| -1% | -$676K | 3.53% | 6 |
|
|
2018
Q2 | $44.1M | Hold |
3,600,954
| – | – | 3.26% | 6 |
|
|
2018
Q1 | $34.4M | Sell |
3,600,954
-55,715
| -2% | -$533K | 2.57% | 9 |
|
|
2017
Q4 | $33M | Buy |
+3,656,669
| New | +$33M | 3.46% | 6 |
|
|
2015
Q4 | – | Sell |
-245,000
| Closed | -$2.01M | – | 92 |
|
|
2015
Q3 | $2.01M | Hold |
245,000
| – | – | 0.32% | 62 |
|
|
2015
Q2 | $3.42M | Buy |
245,000
+75,000
| +44% | +$1.05M | 0.45% | 50 |
|
|
2015
Q1 | $4.09M | Sell |
170,000
-30,000
| -15% | -$721K | 0.63% | 45 |
|
|
2014
Q4 | $3.29M | Buy |
+200,000
| New | +$3.29M | 0.51% | 46 |
|